Browse the evidence

Body Mass Index (BMI) partially mediates the protective effect of physical activity on diabetic retinopathy, accounting for 35.7% to 58.7% of the total benefit, indicating that weight loss is a significant but not exclusive mechanism.

Exercise protects your eyes through two main paths: helping you lose weight (which accounts for about half the benefit) and improving your metabolism directly (the other half). Even if you struggle to lose weight, staying active still provides significant protection against diabetic eye disease through improved blood sugar and reduced inflammation.

Weight loss reduces glomerular hyperfiltration, blood pressure, and proteinuria, thereby providing nephroprotection.

Losing weight through diet and exercise directly protects the kidneys by lowering blood pressure and reducing the workload (hyperfiltration) on the kidney filters. This is the first-line strategy for preventing kidney disease in obese individuals.

Bariatric surgery is an effective and durable weight-loss intervention that reduces major adverse liver outcomes (MALO) and cardiovascular events in patients with MASH, though data in advanced cirrhosis is limited.

Bariatric surgery offers significant long-term benefits for liver and heart health in MASH patients. It should be considered for eligible patients, especially when other treatments fail, despite limited data in advanced cirrhosis.

SGLT2 inhibitors reduce systemic inflammation and oxidative stress by decreasing body fat mass and improving insulin resistance, which lowers inflammatory markers like IL-6 and TNF-alpha.

By helping you lose weight through sugar excretion, SGLT2 inhibitors reduce the inflammation that damages blood vessels, offering protection beyond just lowering blood sugar.

Obesity and overweight status are strongly associated with higher odds of dyslipidemia in Iranian adults, with obese individuals having 2.8 times higher risk compared to normal-weight adults.

Maintaining a healthy weight is crucial for managing blood lipids. In this population, obesity significantly increases the risk of dyslipidemia. Focus on sustainable lifestyle changes including balanced nutrition and regular physical activity to manage weight and improve lipid profiles.

Physical inactivity is associated with increased odds of dyslipidemia, with inappropriate physical activity increasing the odds by 1.2 times compared to appropriate activity.

Regular physical activity helps manage blood lipids. This study found that those with inappropriate physical activity had higher odds of dyslipidemia. Aim for regular moderate-to-vigorous physical activity as part of a healthy lifestyle.

Low-carbohydrate weight-reducing diets produce greater short-term weight loss (3-12 months) than balanced-carbohydrate diets in overweight/obese adults without type 2 diabetes, but this advantage disappears after 12 months.

If you want to lose weight quickly, a low-carb diet might give you a slight edge over a balanced diet in the first year. However, after a year, it offers no advantage over a balanced diet. Choose the diet you can stick to, as long-term weight loss is similar regardless of carb intake.

An energy deficit of approximately 500 kcal per day completely prevents lean mass gains from resistance training.

If your goal is to build muscle while losing fat, a 500 kcal daily deficit will likely result in zero muscle gain. You must either reduce the deficit below 500 kcal/day or accept that muscle growth will be stalled while you lose fat.

A high-intensity lifestyle intervention (ILI) delivered by health coaches in primary care significantly improves HDL cholesterol, total:HDL ratio, and metabolic syndrome severity over 24 months, but fasting glucose improvements are transient (significant at 12 months only).

If you have obesity and are seeing a primary care doctor, ask about a structured lifestyle program delivered by a health coach. This study shows that weekly visits for the first 6 months, followed by monthly check-ins, can significantly improve your 'good' cholesterol (HDL) and overall metabolic health over two years. While blood sugar improvements may fade if weight is not maintained, the lipid benefits persist.

Single-meal energy intake (EI) during ad libitum lunch meals serves as a robust short-term biomarker for predicting subsequent weight loss in adults with obesity treated with liraglutide.

For adults with obesity taking liraglutide, tracking how much you eat during a single lunch can predict your weight loss over the next few weeks. This study shows that a significant drop in lunch energy intake correlates with greater weight loss, making it a useful short-term indicator of treatment effectiveness.

Low-carbohydrate diets induce greater early-phase calorie restriction (approx. 162 kcal/d) compared to low-fat diets, but this advantage is not sustained after 3 months.

If you start a low-carb diet, expect a stronger initial drop in hunger and calorie intake compared to a low-fat diet, but don't rely on this advantage for long-term weight management. The difference disappears after 3 months, so focus on finding a sustainable way to eat that you can maintain indefinitely, regardless of the macronutrient split.

Sustained weight loss (≥7% at 1 year) is associated with significantly lower HbA1c levels at 10 years compared to weight regain, although A1c may still rise slightly from baseline.

If you lose weight through lifestyle changes, keeping it off is crucial for long-term blood sugar control. Even if your blood sugar rises slightly from its lowest point, keeping 7% or more weight off keeps it significantly lower than if you regain the weight. This helps protect your kidneys over the next decade.

Bariatric surgery reduces coronary artery disease (CAD) risk, whereas medical weight loss has not demonstrated a reduction in CAD rates.

If you have severe obesity, bariatric surgery is the only weight loss intervention proven to reduce heart disease risk. Medical weight loss programs have not shown this benefit. Discuss surgery with your doctor if you are a candidate.

Obesity-mediated pathways account for approximately 16% of the diet-associated cancer burden, linking dietary factors like sugar-sweetened beverages and low fruit intake to cancer via BMI increases.

Maintaining a healthy weight through diet can reduce cancer risk via obesity-mediated pathways. Focus on reducing sugar-sweetened beverages and increasing fruit intake, which are key drivers of this specific risk pathway.

SGLT2 inhibitors promote weight loss and improve metabolic parameters (blood pressure, lipid profile, uric acid) by increasing urinary glucose excretion, resulting in an energy deficit of 240-320 kcal/day.

SGLT2 inhibitors help with weight loss by excreting glucose in urine, creating a daily calorie deficit of about 240-320 kcal. This can help reduce abdominal fat and improve blood pressure and lipids. However, weight loss tends to plateau, so combining the medication with lifestyle changes is important for long-term success.

Long-term use of GLP-1 receptor agonists (GLP-1RAs) reduces the incidence of knee surgery and slows cartilage loss velocity in knee osteoarthritis (KOA) patients with comorbid type 2 diabetes, primarily mediated by significant weight loss rather than direct anti-inflammatory effects.

If you have knee osteoarthritis and type 2 diabetes, using GLP-1RAs (like semaglutide or liraglutide) for at least two years can significantly reduce your risk of needing knee surgery and slow down cartilage wear. This benefit comes mainly from the weight loss these drugs cause, which reduces stress on your knees. While they also help with pain, the structural protection is largely weight-dependent. To maximize benefits, combine GLP-1RA therapy with resistance training to preserve muscle mass.

Dietary composition, particularly high carbohydrate intake, can reduce post-weight-loss metabolic expenditure by approximately 200 kcal/day compared to higher fat intakes, contributing to weight regain.

After weight loss, be mindful of high-carbohydrate diets, especially if you have insulin resistance. Higher fat or lower carbohydrate intakes may help preserve metabolic rate, making it easier to maintain your weight.

Intermittent fasting (including 16:8 and 5:2 protocols) produces weight loss equivalent to continuous energy restriction when total caloric intake is matched.

Intermittent fasting (like 16:8 or 5:2) is an effective weight loss strategy, but only because it helps you eat fewer calories. It is not superior to eating fewer calories every day. Choose the pattern that best fits your lifestyle and helps you maintain a caloric deficit.

Lifestyle interventions (diet and physical activity) alone result in modest weight loss (2-9%) and are often insufficient for significant health improvements, though they remain a fundamental component of obesity management.

Lifestyle changes are essential but often result in only modest weight loss (2-9%) that is hard to maintain. For significant health improvements, lifestyle changes should be combined with other treatments like medications or surgery, especially if you have obesity-related health conditions.

A reduction in waist circumference (WC) is significantly associated with a lower risk of heart failure with preserved ejection fraction (HFpEF), but not heart failure with reduced ejection fraction (HFrEF).

For people with type 2 diabetes, reducing waist size is particularly effective at preventing heart failure with preserved ejection fraction (HFpEF). While overall fat loss helps, targeting central adiposity (waist circumference) offers specific protection against this subtype of heart failure. Monitor your waist as a key health indicator.

SGLT-2 inhibitors and DPP-4 inhibitors produce modest or neutral weight loss effects, respectively, making them less effective for weight management compared to GLP-1 agonists.

SGLT-2 inhibitors offer modest weight loss (3-5%), while DPP-4 inhibitors are generally weight-neutral or have mild effects. They are less effective for weight management than GLP-1 agonists. SGLT-2 inhibitors work by excreting glucose in urine, but compensatory mechanisms limit weight loss. DPP-4 inhibitors are better suited for glycemic control without significant weight impact.

Weight loss outcomes (kg or % loss) in behavioral interventions do not consistently favor either 'more' or 'less' advantaged groups, with most trials finding no significant difference in weight loss by socioeconomic or demographic status.

Your socioeconomic background does not predict your weight loss success. While you might face more barriers to starting or sticking with a program, if you do complete it, you are likely to lose the same amount of weight as anyone else.

Ketogenic diets (less than 50g carbohydrate/day) induce nutritional ketosis, shifting the body's primary fuel source from glucose to ketones and fatty acids, which may provide unique therapeutic benefits beyond weight loss.

If you want to enter ketosis, restrict carbohydrates to under 50 grams per day while maintaining moderate protein intake. Expect your body to switch to burning fat and ketones for fuel. Monitor your electrolytes to avoid initial side effects.

Caloric restriction (CR) and exercise extend lifespan and delay age-related diseases by targeting mitochondrial function, specifically through enhanced ATP production, improved Ca2+ homeostasis, and activation of AMPK/SIRT1 pathways.

To leverage mitochondrial health for longevity, prioritize regular physical activity and consider moderate caloric restriction. Exercise directly improves mitochondrial biogenesis and Ca2+ handling, while CR enhances energy production and antioxidant defenses. Focus on nutrient density to maintain health while reducing overall intake.